Update on laboratory diagnosis of human brucellosis

International Journal of Antimicrobial Agents

Volumn 36, Issue SUPPL. 1, 2010, Pages

  Araj, George F ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Brucellosis; Diagnostic tests; Immunoassay; Serologic tests

Indexed keywords

AGGLUTINATION TEST; ANTIGEN DETECTION; ARTICLE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLOSIS; COOMBS TEST; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GOLD STANDARD; HUMAN; IMMUNOCHROMATOGRAPHIC LATERAL FLOW ASSAY; IMMUNOFLUORESCENCE; LABORATORY DIAGNOSIS; MICROAGGLUTINATION TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; ROSE BENGAL SLIDE AGGLUTINATION TEST; SEROLOGY; SERUM AGGLUTINATION TEST;

BACTERIOLOGICAL TECHNIQUES; BRUCELLA; BRUCELLOSIS; FEMALE; HUMANS; IMMUNOASSAY; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES;

EID: 77957946230     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.06.014     Document Type: Article

References (76)

1. Bruce D. Note on the discovery of a microorganism in Malta Fever. Practitioner 1887, 36:161-170.
2. Wyatt H.V. Sir Themistocles Zammit: His honors and an annotated bibliography of his medical work. Maltese Med J 2000, 12:27-30.
3. Araj G.F. Human brucellosis revisited: a persistent saga in the Middle East. BMJ (Middle East) 2000, 7:6-15.
4. Pappas G., Papadimitriou P., Akritidis L.N., Christou, Tsianos E. The new global map of human brucellosis. Lancet Infect Dis 2006, 6:91-99.
5. Lulu A.R., Araj G.F., Khateeb M.I., Mustafa M.Y., Yusuf A.R., Fenech F.F. Human brucellosis in Kuwait: a prospective study of 400 cases. Quart J Med 1988, 66:39-54.
6. Young E.J. An overview of human brucellosis. Clin Infect Dis 1995, 21:283-290.
7. Memish Z.A., Balkhy H.H. Brucellosis and international travel. J Travel Med 2004, 11:49-55.
8. Godfroid J., Cloeckaert A., Liautard J., Kohler S., Fretin D., Walravens K., et al. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res 2005, 36:313-326.
9. Greenfield R.A., Drevets D.A., Machado L.J., Voskuhl G.W., Cornea P., Bronze M.S. Bacterial pathogens as biological weapons and agents of bioterrorism. Am J Med Sci 2002, 323:299-315.
10. Pappas G., Pangopoulou P., Christou L., Akritidis N. Category B potential bioterrorism agents: bacteria, viruses, toxins, and foodborne and waterborne pathogens. Infect Dis Clin North Am 2006, 20:395-421.
11. Alton G.G., Jones L.M., Angus R.D., Verger J.M. Techniques for the brucellosis laboratory 1988, Institut National de la Recherche Agronomique, Paris.
12. Corbel M.J. Brucellosis: an overview. Emerg Infect Dis 1997, 3:213-221.
13. Foster G., Osterman B.S., Godfroid J., Jacques I., Cloeckaert A. Brucella ceti sp. nov. and Brucella pinnipedialis sp. nov. for Brucella strains with cetaceans and seals as their preferred hosts. Int J Syst Evol Microbiol 2007, 57:2688-2693.
14. Whatmore A.M. Current understanding of the genetic diversity of Brucella, an expanding genus of zoonotic pathogens. Infect Genet Evol 2009, 9:1168-1184.
15. Brew S.D., Perrett L.L., Stack J.A., MacMillan A.P. Human exposure to Brucella recovered from a sea mammal. Vet Rec 1999, 24:483.
16. Sohn A.H., Probert W.S., Glaser C.A., Gupta N., Bollen A.W., Wong J.D., et al. Human neurobrucellosis with intra-cerebral granuloma caused by a marine mammal Brucella spp. Emerg Infect Dis 2003, 9:485-488.
17. McDonald W.L., Jamaludin R., Mackereth G., Hansen M., Humphrey S., Short P. Characterisation of a Brucella sp. strain as a marine-mammal type despite isolation from a patient with spinal osteomyelitis in New Zealand. J Clin Microbiol 2006, 44:4363-4370.
18. Drancourt M., Brouqui P., Raoult D. Afipia clevelandensis antibodies and cross-reactivity with Brucella spp. and Yersinia enterocolitica O:9. Clin Diag Lab Immunol 1997, 4:748-752.
19. Goldbaum F.A., Leoni J., Wallach J.C., Fossati C.A. Characterization of an 18-kilodalton Brucella cytoplasmic protein which appears to be a serological marker of active infection of both human and bovine brucellosis. J Clin Microbiol 1993, 31:2141-2145.
20. Moriyon I., Lopez-Goni I. Structure and properties of the outer membranes of Brucella abortus and Brucella melitensis. Int Microbiol 1998, 1:19-26.
21. Oliveira S., Splitter G.A. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 1996, 14:959-962.
22. Franco M.P., Mulder M., Gilman R.H., Smits H.L. Human brucellosis. Lancet Infect Dis 2007, 7:775-786.
23. Yagupsky P., Baron E.J. Laboratory exposures to Brucellae and implications for bioterrorism. Emerg Infect Dis 2005, 11:1180-1185.
24. Gorvel J.-P. Brucella: a Mr " Hide" converted into Dr Jekyll. Microb Infect 2008, 10:1010-1013.
25. Imbodin J.B., Canter A., Cluff L.E., Trever R.W. Brucellosis: III. Psychologic aspects of delayed convalescence. AMA Arch Intern Med 1959, 103:404-414.
26. Spink W.W. The nature of brucellosis 1956, University of Minnesota Press, Minneapolis.
27. Sharda D.C., Lubani M.M. A study of brucellosis in childhood. Clin Pediatr 1986, 25:492-495.
28. Lubani M.M., Dudin K.I., Sharda D.C., Manadhar D.S., Araj G.F., Hafez A.H. A multicenter therapeutic study of 1100 children with brucellosis. Pediatr Infect Dis J 1989, 8:75-78.
29. Madkour M.M. Overview. Brucellosis 1989, 71-89. Butterworths, London. M.M. Madkour (Ed.).
30. Colmenero J.D., Reguera J.M., Martos F., Sanchez-De-Mora D., Delgado M., Causse M., et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 1996, 75:195-211.
31. Corbel M.J., Beeching N.J. Brucellosis. Harrison's principles of internal medicine 2005, vol. 1:914-917. McGraw-Hill, New York. 16th ed.
32. Pappas G., Akritidis N., Bosilkovski M., Tsianos E. Brucellosis. New Engl J Med 2005, 35:2325-2336.
33. Mantur B.G., Amarnath S.K., Shinde R.S. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol 2007, 25:188-202.
34. Araj G.F., Lulu A.R., Mustafa M.Y., Khateeb M.I. Evaluation of ELISA in the diagnosis of acute and chronic brucellosis in human beings. J Hyg (London) 1986, 97:457-469.
35. Yagupsky P. Detection of brucellae in blood cultures. J Clin Microbiol 1999, 37:3437-3442.
36. Araj G.F., Kattar MM Rapid diagnosis of human brucellosis using the Bact/Alert continuous culture monitoring system. Abstracts of the 103rd annual meeting of the American Society for Microbiology 2003, (abstract C-002).
37. Al-Dahouk S., Le Flèche P., Nöckler K., Jacques I., Grayon M., Scholz H.C., et al. Evaluation of Brucella MLVA typing for human brucellosis. J Microbiol Methods 2007, 69:137-145.
38. Kattar M.K., Jaafar R.F., Araj G.F., Le Flèche P., Matar G.M., Abi Rached R., et al. Evaluation of a multilocus variable-number tandem-repeat analysis scheme for typing human Brucella isolates in a region of brucellosis endemicity. J Clin Microbiol 2008, 46:3935-3940.
39. Araj G.F. Human brucellosis: a classical infectious disease with persistent diagnostic challenges. Clin Lab Sci 1999, 12:207-212.
40. Ruiz-Mesa J.D., Sánchez-Gonzalez J., Reguera J.M., Martin L., Lopez-Palmero S., Colmenero J.D. Rose Bengal test: diagnostic yield and use for the rapid diagnosis of human brucellosis in emergency departments in endemic areas. Clin Microbiol Infect 2005, 11:221-225.
41. Gómez M.C., Nieto J.A., Rosa C., Geijo P., Escribano M.A., Muñoz A., et al. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol 2008, 15:1031-1033.
42. Araj G.F., Kaufman A.F. Determination of Brucella specific IgG, IgM and IgA by ELISA in sera of patients with brucellosis against, B. melitensis major outer membrane proteins (MOMP) and whole cell heat killed (HK) antigens. J Clin Microbiol 1989, 27:1909-1912.
43. Rose J.E., Roepke M.H. An acidified antigen for detection of nonspecific reactions in the plate-agglutination test for bovine brucellosis. Am J Vet Res 1957, 18:550-555.
44. Araj G.F., Brown G.M., Haj M.M., Madhavan N.V. Assessment of brucellosis card test in screening patients for brucellosis. Epidemiol Infect 1988, 100:389-398.
45. Araj G.F., Awar G.N. The value of ELISA vs negative Coombs findings in the serodiagnosis of human brucellosis. Serodiag Immunother Infect Dis 1997, 8:169-172.
46. Orduña A., Almarza A., Prado A., Gutierrez M.P., Garcia-Pascual A., Duenãs A., et al. Evaluation of an immunocapture-agglutination test (Brucellacapt) for serodiagnosis of human brucellosis. J Clin Microbiol 2000, 11:4000-4005.
47. Araj G.F., Azzam R.A. Seroprevalence of brucella antibodies among persons in high-risk occupation in Lebanon. Epidemiol Infect 1996, 117:281-288.
48. Araj G., Kattar M., Fattouh L.G., Bajakian O.K., Kobeissi S.A. Evaluation of the PANBIO Brucella immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays for diagnosis of human brucellosis. Clin Diagn Lab Immunol 2005, 12:1334-1335.
49. Araj G.F. Profiles of Brucella-specific immunoglobulin G subclass in serum of patients with acute and chronic brucellosis. Serodiag Immunother Infect Dis 1988, 2:401-410.
50. Araj G.F., Lulu A.R., Khateeb M.I., Haj M.M. Specific IgE response in patients with brucellosis. Epidemiol Infect 1990, 105:571-577.
51. Araj G.F., Dhar R., Lastimoza J.L., Haj M. Indirect fluorescent antibody test versus enzyme linked immunosorbent assay and agglutination tests in the serodiagnosis of patient with brucellosis. Serodiag Immunother Infect Dis 1990, 4:1-8.
52. Smits H.L., Abdoel T.H., Solera J., Clavijo E., Dial R. Immunochromatographic Brucella-specific immunoglobulin M and G lateral flow assay for rapid serodiagnosis of human brucellosis. Clin Diagn Lab Immunol 2003, 10:1141-1146.
53. Mizanbayeva S., Smits H.L., Zhalilova K., Abdoel T.H., Kozakov S., Ospanov K.S., et al. The evaluation of a user-friendly lateral flow assay for the serodiagnosis of human brucellosis in Kazakhstan. Diagn Microbial Infect Dis 2009, 65:14-20.
54. Gazapo E., Gonzalez Lahoz J., Subiza J.L., Banquero M., Jil J., de la Concha E.G. Changes in IgM and IgG antibody concentration in brucellosis over time: importance for diagnosis and follow-up. J Infect Dis 1989, 219-225.
55. Ariza J., Pellicer T., Pallares R., Fox Z., Gudiol F. Specific antibody profile in human brucellosis. Clin Infect Dis 1992, 14:131-140.
56. Kattar M.M., Zallou P.A., Araj G.F., Samaha-Kfoury J., Shbaklo H., Kanj S.K., et al. Development and evaluation of real-time polymerase chain reaction assays on whole blood and paraffin-embedded tissues for rapid diagnosis of human brucellosis. Diagn Microbiol Infect Dis 2007, 59:23-32.
57. Araj G.F., Lulu A.R., Saadah M.A., Mousa A.M., Strannegard I.L., Shakir R.A. Rapid diagnosis of central nervous system brucellosis by ELISA. J Neuroimmunol 1986, 2:73-82.
58. Araj G.F., Lulu A.R., Khateeb M.I., Saadah M.A., Shakir R.A. ELISA versus routine tests in the diagnosis of patients with systemic and neurobrucellosis. Acta Pathol Microbiol Scand 1988, 96:171-176.
59. Pellicer T., Ariza J., Fox Z., Pallares R., Gudiol F. Specific antibodies during relapse of human brucellosis. J Infect Dis 1988, 57:918-924.
60. Baldi P.C., Miguel S.E., Fossati C.A., Wallach J.C. Serologic follow-up of human brucellosis by measuring IgG antibodies to LPS and cytoplasmic proteins of Brucella species. Clin Infect Dis 1996, 22:446-455.
61. Mantecon M.A., Gutierrez P., del Pilar Zarzosa M., Duenas A.I., Solera J., Fernandez-Lago L., et al. Utility of an immunocapture-agglutination test and an enzyme-linked immunosorbent assay test against cytosolic proteins from Brucella melitensis B115 in the diagnosis and follow-up of human acute brucellosis. Diagn Microbiol Infect Dis 2006, 55:27-35.
62. Ariza J., Corredoira J., Pallares R., Vilarich P.F., Rufi G., Pujol M., et al. Characteristics of and risk factors for relapse of brucellosis in humans. Clin Infect Dis 1995, 20:1241-1249.
63. Makis A.C., Galanakis E., Hatzimichael E.C., Papadopoulou Z.L., Siamopoulou A., Bourantas K.L. Serum levels of soluble interleukin-2 receptor alpha (sIL-2Ralpha) as a predictor of outcome in brucellosis. J Infect 2005, 51:206-210.
64. Goldbaum F.A., Rubbi C.P., Wallach J.C., Miguel S.E., Baladi P.C., Fossati C.A. Differentiation between active and inactive human brucellosis by measuring antiprotein humoral immune responses. J Clin Microbiol 1992, 30:604-607.
65. Rossetti O.L., Arese A.I., Boschiroli M.L., Cravero S.L. Cloning of B. abortus gene and characterization of expressed 26-kilodalton periplasmic protein: potential use for diagnosis. J Clin Microbiol 1996, 34:165-169.
66. Mayefield J.E., Mayfield J.E., Bricker B.J., Godfrey H., Crosby R.M., Knight D.J., et al. The cloning, expression and nucleotide sequence of a gene (BCS P31) coding for an immunogenic Brucella abortus protein (31kDa). Gene 1988, 63:1-9.
67. Romero C., Gamazo C., Pardo M., Lopez-Goni I. Specific detection of Brucella DNA by PCR. J Clin Microbiol 1995, 33:615-617.
68. Morata P., Queipo-Ortuno M.I., Reguera J.M., Miralles F., Lopez-Gonzalez J.J., Colmenero J.D. Diagnostic yield of a PCR assay in focal complications of brucellosis. J Clin Microbiol 2001, 39:3743-3746.
69. Probert W.S., Schrader K.N., Khuong N.Y., Bystrom S.L., Graves M.H. Real-time multiplex PCR assay for detection of Brucella spp., B. abortus, and B. melitensis. J Clin Microbiol 2004, 42:1290-1293.
70. Vrioni G., Gartzonika C., Kostoula A., Boboyiami C., Papadopoulou C., Levidiotou S. Application of a polymerase chain reaction enzyme immunoassay in peripheral whole blood and serum specimens for diagnosis of acute human brucellosis. Eur J Clin Microbiol Infect Dis 2004, 23:194-199.
71. DeBeaumont C., Falconnet P.A., Maurin M. Real-time PCR for detection of Brucella spp. DNA in human serum samples. Eur J Clin Microbiol Infect Dis 2005, 24:842-845.
72. Navarro E., Segura J.C., Castaño M.J., Solera J. Use of real-time quantitative polymerase chain reaction to monitor the evolution of Brucella melitensis DNA load during therapy and post-therapy follow-up in patients with brucellosis. Clin Infect Dis 2006, 42:1266-1273.
73. Mitka S., Anetakis C., Souliou E., Diza E., Kansouzidou A. Evaluation of different PCR assays for the early detection of acute and relapsing human brucellosis in comparison with conventional methods. J Clin Microbiol 2007, 45:1211-1218.
74. Navarro-Martinez A., Navarro E., Castano M.J., Solera J. Rapid diagnosis of human brucellosis by quantitative real-time PCR: a case report of brucellar spondylitis. J Clin Microbiol 2008, 46:385-387.
75. Quipo-Ortuño M.I., Colmenero J.D., Bravo M.J., García-Ordoñez M.A., Morata P. Usefulness of a quantitative real-time PCR assay using serum samples to discriminate between inactive, serologically positive and active human brucellosis. Clin Microbiol Infect 2008, 14:1128-1134.
76. Quipo-Ortuño M.I., Tena F., Colmenero J.D., Morata P. Comparison of seven commercial DNA extraction kits for the recovery of Brucella DNA from spiked human serum samples using real-time PCR. Eur J Clin Microbiol Infect Dis 2008, 27:109-114.